Sibannac Inc (SNNC)
0.009
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sibannac Total Liabilities (Quarterly): 0.6156M for Aug. 31, 2016
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2017 | 0.6585M |
| November 30, 2016 | 0.6399M |
| August 31, 2016 | 0.6156M |
| May 31, 2016 | 0.5669M |
| February 29, 2016 | 0.605M |
| November 30, 2015 | 0.5122M |
| August 31, 2015 | 0.5067M |
| May 31, 2015 | 0.0116M |
| February 28, 2015 | 0.0092M |
| November 30, 2014 | 0.0328M |
| Date | Value |
|---|---|
| August 31, 2014 | 0.1378M |
| May 31, 2014 | 0.7451M |
| February 28, 2014 | 0.7105M |
| November 30, 2013 | 0.6588M |
| August 31, 2013 | 0.6527M |
| May 31, 2013 | 0.5381M |
| February 28, 2013 | 0.5178M |
| November 30, 2012 | 0.493M |
| August 31, 2012 | 0.4644M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.3228M |
| Shareholders Equity (Quarterly) | -0.2928M |